|
|
|
|
|
|
Neurocrine Bioscienc (NBIX)
|
|
47.35 +0.23 (+0.49%)
|
6/23/2017 4:00pm
|
|
Open:
|
46.98
|
Pre. Close:
|
47.12
|
|
High:
|
47.54
|
Low:
|
46.17
|
|
Volume:
|
1,048,289
|
Market Cap:
|
4.17B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
47.66 - 48.64
|
48.64 - 49.47
|
|
Low:
|
44.03 - 44.83
|
44.83 - 45.51
|
|
Close:
|
45.62 - 47.19
|
47.19 - 48.52
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:36:50 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 57.73 One year: 63.27
|
|
Support:
|
Support1: 41.76 Support2: 34.74
|
|
Resistance:
|
Resistance1:
49.43 Resistance2: 54.17
|
|
Pivot:
|
45.16 
|
|
Moving Averages:
|
MA(5): 46.59 MA(20): 45.41 
MA(100): 46.51 MA(250): 46.61
|
|
MACD:
|
MACD(12,26):
-0.87 Signal(12,26,9): -1.36
|
|
%K %D:
|
%K(14,3): 86.64 %D(3): 77.29
|
|
RSI:
|
RSI(14): 51.70
|
|
52-Week:
|
High: 55.38
Low: 37.35 Change(%): 6.2
|
|
Average Vol(K):
|
3-Month: 1411
10-Days 974
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.NBIX has closed below upper band by 11.3%. Bollinger Bands are 29.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 02 Jun 2017 13:18:45 GMT
Neurocrine Announces Presentations Related to INGREZZA® (valbenazine) Capsules ...
Fri, 23 Jun 2017 16:41:15 GMT
Option Market Alert: Neurocrine Biosciences Inc Implied Price Swing Hits An ...
Sun, 04 Jun 2017 22:30:00 GMT
Neurocrine Biosciences to Present at the Goldman Sachs 38th Annual Global ...
Thu, 08 Jun 2017 18:56:15 GMT
Neurocrine Biosciences, Inc. (NBIX): From Top to Bottom
Thu, 01 Jun 2017 16:52:30 GMT
Digging Up the Facts on Neurocrine Biosciences, Inc. (NBIX)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
